When patient complains of chest pain
Derived from tetracycline family
Treats sinusitis, pneumonia
New use for drug originally designed to treat diabetic pain
Boosts older shots that may have worn off
Rare condition can destroy heart
May benefit up to 8 million Americans
Compelling urge to move legs, often during sleep
Also protects against tetanus and diphtheria
Gila monster derivative helps manage blood sugar
Patients should have more say in treatment decisions, some experts say
Study finds consumption can lower chances of disease by as much as 22%
Use nesiritide only as "last resort," researchers say
Kills bacteria that cause gum inflammation
Herb's safety and FDA's power to regulate it at issue, experts say
Non-cox-2 painkiller plus an acid-reducer is safer and cheaper, study finds
FDA says it's evaluating the ruling before deciding whether to appeal
Debate surrounds decision to choose one product over another
Also lets doctors monitor self care
Second company persuasive in saying newer implants are safer
Some believe the decision to use the drug should stay with physicians
Guards against fluid leakage from incision
Move follows FDA concerns about drug's health risks
For people age 12 and older
Condition affects 1 in 10 women of childbearing age
Slows virus that causes deadly liver disease
For postmenopausal women
But an agency official denies the accusation
Prevents rupture of aortic weak spot
Some patients quit cox-2 therapy; others have cut back as questions remain
With radiation, Temodar can extend patients' lives, FDA says
First Type 1 treatment since insulin
New England Journal of Medicine article claims agency too tied to industry
Less show, more show-and-tell seen in wake of drug safety hearings
300,000 Americans infected with both
Group says some children suffer rare, deadly syndrome after taking it
Blood pressure drug assumes dual role
The painkillers' problems haven't gone away, they say
Advisers vote to recommend keeping Celebrex, Vioxx and Bextra available while finding all raise cardiovascular risks
Tames rare skin infection
Hearing gets personal tales of pain relief with cox-2s
Vioxx increases heart dangers dramatically, Graham tells government advisers
First of three days of testimony gets underway
Results will be focus of three days of government hearings
Other research finds more evidence of heart attack, stroke risk
Panel must balance health risks against benefits
As many as 40 percent of cases may have been fatal, FDA scientist contends
Advisers cite need for medical supervision when taking statins
FDA offers some advice
It also suggests stricter regulation of dietary supplements